|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 24.83 USD | +0.40% |
|
+7.86% | +50.39% |
| 08-07 | UBS Adjusts Price Target on Denali Therapeutics to $34 From $25, Maintains Buy Rating | MT |
| 08-07 | Wedbush Adjusts PT on Denali Therapeutics to $27 From $26, Maintains Outperform Rating | MT |
| Market Cap | 3.94B 3.41B 3.18B 2.92B 5.49B 375B 5.58B 37.35B 14.66B 188B 14.8B 14.47B 621B | P/E 2026 * |
-11.1x | P/E 2027 * | -10.8x |
|---|---|---|---|---|---|
| Enterprise Value | 3.31B 2.87B 2.68B 2.45B 4.62B 315B 4.69B 31.4B 12.32B 158B 12.44B 12.17B 522B | EV / Sales 2026 * |
49.1x | EV / Sales 2027 * | 25.8x |
| Free-Float |
89.44% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Denali Therapeutics Inc.
| 1 day | +0.40% | ||
| 1 week | +7.86% | ||
| Current month | +7.86% | ||
| 1 month | -6.97% | ||
| 3 months | +26.55% | ||
| 6 months | +17.79% | ||
| Current year | +50.39% |
| 1 week | 22.63 |  | 25.74 |
| 1 month | 22.01 | | 27.11 |
| Current year | 15.34 | | 27.3 |
| 1 year | 12.58 | | 27.3 |
| 3 years | 10.57 | | 33.33 |
| 5 years | 10.57 | | 56.8 |
| 10 years | 10.57 | | 93.94 |
| Manager | Title | Age | Since |
|---|---|---|---|
Alexander Schuth
DFI | Director of Finance/CFO | 52 | 30/04/2022 |
Ryan Watts
CEO | Chief Executive Officer | 50 | 31/07/2015 |
Peter Chin
CTO | Chief Tech/Sci/R&D Officer | 58 | 05/11/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Ryan Watts
BRD | Director/Board Member | 50 | 28/02/2015 |
Jay Flatley
BRD | Director/Board Member | 73 | 31/03/2015 |
David Schenkein
BRD | Director/Board Member | 68 | 31/03/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 03/06/26 | Free | Director | 25,634 | 0.0162% | ||
| 10/04/26 | Other | Chief Technology Officer | 204,402 | 0.1289% | ||
| 06/01/26 | Sell | Founder | 17,218 | 0.0110% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.40% | +7.86% | +77.87% | -3.87% | 3.94B | |
| +8.49% | +20.55% | +70.77% | +110.32% | 68.12B | |
| +1.25% | +2.44% | +34.27% | +70.43% | 55.18B | |
| -1.09% | +32.96% | +19.67% | +494.56% | 28.63B | |
| +10.83% | +18.38% | +56.20% | +6.03% | 23.99B | |
| +2.72% | +3.41% | -16.11% | -7.96% | 23.53B | |
| +6.50% | +7.56% | +44.65% | -21.73% | 18.45B | |
| +6.20% | +11.51% | +33.87% | +693.38% | 16.44B | |
| -3.88% | +16.98% | +199.30% | +359.77% | 15.83B | |
| +3.58% | +1.96% | +43.35% | +163.76% | 13.4B | |
| Average | +3.50% | +11.30% | +56.38% | +186.47% | 26.75B | |
| Weighted average by Cap. | +4.30% | +13.02% | +51.09% | +165.94% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 67.47M 58.36M 54.5M 49.99M 94.03M 6.42B 95.52M 639M 251M 3.22B 253M 248M 10.64B | 126M 109M 101M 93.08M 175M 11.95B 178M 1.19B 467M 5.99B 472M 461M 19.81B |
| Net income | -444M -384M -359M -329M -619M -42.24B -628M -4.21B -1.65B -21.17B -1.67B -1.63B -70B | -444M -384M -359M -329M -620M -42.3B -629M -4.21B -1.65B -21.2B -1.67B -1.63B -70.1B |
| Net Debt | -628M -543M -507M -465M -875M -59.77B -889M -5.95B -2.34B -29.96B -2.36B -2.31B -99.04B | -695M -601M -562M -515M -969M -66.16B -984M -6.59B -2.59B -33.16B -2.61B -2.55B -110B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/08/26 | US$24.83 | +0.40% | 1,750,014 |
| 06/08/26 | US$24.73 | +1.27% | 3,049,280 |
| 05/08/26 | US$24.42 | +1.03% | 1,094,213 |
| 04/08/26 | US$24.17 | +4.41% | 993,770 |
| 03/08/26 | US$23.15 | +0.56% | 1,476,216 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- DNLI Stock
Select your edition
All financial news and data tailored to specific country editions
